Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 4, 2015 IBIO A 150,000 $1.72 $258,000 300,000 Direct +100.00% Acquired -100.0% (price as of 2026-10-02)
Sept. 5, 2014 IBIO A 50,000 $0.49 $24,500 150,000 Direct +50.00% Acquired -100.0% (price as of 2026-10-02)
Jan. 24, 2014 IBIO A 100,000 · · 100,000 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Sept. 4, 2015 IBIO Stock Option (right to buy) Common Stock (150,000) $1.72 Sept. 4, 2025 150,000 Acquired
Sept. 5, 2014 IBIO Stock Option (right to buy) Common Stock (50,000) $0.49 Sept. 5, 2024 50,000 Acquired
Jan. 24, 2014 IBIO Stock Option (right to buy) Common Stock (100,000) $0.58 Jan. 23, 2024 100,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
April 7, 2014 IBIO Common Stock 22,834 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

IBIO

CFO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2017 $112,500 · · · · · · $112,500
2016 $99,000 · · $94,099 · · · $193,099
2015 $48,000 $0 · $21,263 · · · $69,263

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.